Eric P. Lefkofsky Sells 476,209 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 476,209 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the transaction, the chief executive officer now directly owns 6,502,643 shares in the company, valued at $324,091,727.12. The trade was a 6.82 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tempus AI Stock Down 6.3 %

Tempus AI stock opened at $51.40 on Friday. The firm has a 50 day simple moving average of $44.36 and a 200 day simple moving average of $47.68. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49.

Analyst Ratings Changes

A number of brokerages have recently weighed in on TEM. Bank of America boosted their target price on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Loop Capital reduced their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Wolfe Research initiated coverage on Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 target price on the stock. Piper Sandler restated a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Guggenheim began coverage on shares of Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $56.36.

Hedge Funds Weigh In On Tempus AI

Several hedge funds have recently made changes to their positions in the stock. Novo Holdings A S bought a new position in Tempus AI in the 2nd quarter worth about $142,605,000. ARK Investment Management LLC boosted its stake in Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after buying an additional 1,855,459 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its position in Tempus AI by 1,591.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after buying an additional 1,145,698 shares in the last quarter. NEA Management Company LLC increased its stake in Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after acquiring an additional 813,169 shares during the last quarter. Finally, Perceptive Advisors LLC purchased a new stake in shares of Tempus AI in the 2nd quarter valued at about $9,625,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.